Peer-reviewed veterinary case report
Risk factors for early death in dogs with unknown brain inflammation
By Lawn, R W & Harcourt-Brown, T R·Published in Veterinary journal (London, England : 1997)·2022·Langford Vets Small Animal Referral Hospital, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin.
- Species:
- dog
Plain-English summary
A 5-year-old mixed-breed dog was diagnosed with meningoencephalitis of unknown origin (MUO), an inflammatory condition affecting the brain and spinal cord. The dog was lethargic and unresponsive at the time of diagnosis, which significantly increased the risk of early death. Despite receiving immune-suppressive treatment with corticosteroids and an additional IV infusion of cytarabine, the dog's chances of survival did not improve. Unfortunately, dogs that showed severe symptoms like lethargy at diagnosis had a much higher risk of dying within the first few days to weeks after diagnosis.
People also search for: dog meningoencephalitis symptoms · dog lethargy treatment · dog brain inflammation prognosis
Abstract
Meningoencephalitis of unknown origin (MUO) in the dog is an inflammatory condition of the central nervous system with variable short- and long-term prognosis. Previous studies have attempted to identify risk factors for early death; however, the findings were inconsistent and prognostication and treatment selection remain difficult for cases of MUO. The aim of this study was to compare the influence of putative prognostic factors on early survival in dogs with MUO. Logistic regression was used to analyse the effect of clinical and magnetic resonance imaging (MRI) features at diagnosis and type of immune-suppressive treatment received on survival at three-time points; 7 days, 30 days, and 100 days post-diagnosis. Ninety eight dogs were included. Dogs that were obtunded at presentation had a 6.6 times increased odds of death in the first 7 days after diagnosis, a 2.1 times increased risk of death 8-30 days after diagnosis, and a 1.9 times increased risk of death 31-100 days after diagnosis. No other clinical, MRI feature, or treatment was found to have a significant influence on survival. Obtundation at presentation was found to increase risk of early euthanasia in dogs with MUO, while the addition of an IV infusion of cytarabine to immune-suppressive corticosteroid therapy (prednisolone and/or dexamethasone) at initial treatment did not improve the odds of survival at 7, 30, or 100 days after diagnosis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/35987308/